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Anticipation, manifested through decreasing age of onset or increased severity in successive generations, has been noted in
several genetic diseases. Statistical methods for genetic anticipation range from a simple use of the paired t-test for age of
onset restricted to affected parent-child pairs to a recently proposed random effects model which includes extended
pedigree data and unaffected family members [Larsen et al., 2009]. A naive use of the paired t-test is biased for the simple
reason that age of onset has to be less than the age at ascertainment (interview) for both affected parent and child, and this
right truncation effect is more pronounced in children than in parents. In this study, we first review different statistical
methods for testing genetic anticipation in affected parent-child pairs that address the issue of bias due to right truncation.
Using affected parent-child pair data, we compare the paired t-test with the parametric conditional maximum likelihood
approach of Huang and Vieland [1997] and the nonparametric approach of Rabinowitz and Yang [1999] in terms of Type I
error and power under various simulation settings and departures from the modeling assumptions. We especially
investigate the issue of multiplex ascertainment and its effect on the different methods. We then focus on exploring genetic
anticipation in Lynch syndrome and analyze new data on the age of onset in affected parent-child pairs from families seen
at the University of Michigan Cancer Genetics clinic with a mutation in one of the three main mismatch repair (MMR)
genes. In contrast to the clinic-based population, we re-analyze data on a population-based Lynch syndrome cohort, derived
from the Danish HNPCC-register. Both datasets indicate evidence of genetic anticipation in Lynch syndrome. We then
expand our review to incorporate recently proposed statistical methods that consider family instead of affected pairs as the
sampling unit. These prospective censored regression models offer additional flexibility to incorporate unaffected family
members, familial correlation and other covariates into the analysis. An expanded dataset from the Danish HNPCC-register
is analyzed by this alternative set of methods. Genet. Epidemiol. 34:756–768, 2010. r 2010 Wiley-Liss, Inc.
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INTRODUCTION
Genetic anticipation is a term that refers to an earlier age
of onset or increased disease severity in successive
generations. Trinucleotide repeat expansions are a well-known
explanation of this phenomenon in some Mendelian
disorders, though alternative mechanistic explanations
have also been suggested [Fraser, 1997; La Spada, 1997].
While investigating anticipation and assessing the find-
ings of a study, one has to be cautious about multiple
sources of biases that can affect the results and the choice
of appropriate statistical techniques. The ‘‘naive’’ approach
to test for anticipation is a paired t-test comparing the
difference in mean ages of onset of affected children and
affected parents. Unfortunately, as demonstrated by
Heiman et al. [1996], truncation bias occurs with older
generations having longer follow-up time and later
generations not being followed throughout the entire
‘‘at-risk’’ period. This can dramatically increase the type
I error of a t-test. A nonparametric alternative, like the
matched-pairs signed-rank Wilcoxon test, is another
potential choice but is still subject to the same truncation
bias [Westphalen et al., 2005]. A sensible but crude way to
minimize truncation bias is to limit the analysis to older
birth cohorts (e.g., with affected parents and children both
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born before 1920) [Nilbert et al., 2009; Picco et al., 2001;
Westphalen et al., 2005], which allows adequate follow-up
time for both generations. But this entails a loss of sample
size and consequently a loss of power for detecting
anticipation effects. This restriction does not make full
utilization of the data available in many newer cohorts.
Apart from truncation bias, other factors that could
influence findings on genetic anticipation are secular
trends, such as a change in diagnostic techniques or
reporting protocols, or the introduction of new environ-
mental toxicants/carcinogens that could affect specific
birth cohorts. Also prevalent is ascertainment bias where
findings are derived from multiplex families ascertained
for genetic studies. Such families are enriched with early-
onset cases and preferentially selected due to the presence
of multiply affected individuals, as opposed to a popula-
tion-based sample of affected parent-child pairs.
The objective of this paper is twofold. We first review an
array of statistical approaches to evaluate genetic anticipa-
tion as measured by differences in the age of onset in
successive generations. The primary study design we
consider is that which samples affected parent-child pairs
from existing cohorts. To this end, we present simulation
results that compare the naive paired t-test with para-
metric and nonparametric approaches that account for bias
due to right truncation [Huang and Vieland, 1997;
Rabinowitz and Yang, 1999]. We present comparison of
these methods under random ascertainment as well as
multiplex ascertainment and summarize recommenda-
tions in terms of adopting these methods for a given
analysis. We then consider another study design which
includes all at-risk family members in a predefined cohort
(affected and unaffected) and follows them prospectively.
The variable of interest is the age of diagnosis and we
review survival methods to evaluate risk by relative type
[Daugherty et al., 2005; Larsen et al., 2009]. Censoring
events are age at death, age at last follow-up visit or
censored at age 85 years. Here, missing data are not right
truncated but right censored, which is accounted for in the
survival regression models. Figure A1 in the Appendix
gives a simple schematic representation of the two
different sampling strategies and the corresponding
statistical methods with references.
We then turn our attention to assess evidence of
anticipation in hereditary nonpolyposis colorectal cancer
(HNPCC)/Lynch syndrome in two family cohorts poten-
tially representing two distinct sets of multiplex ascertain-
ment probabilities. One is a population-based cohort of all
Danish families identified with pathogenic mutations in
the mismatch repair (MMR) gene. Nilbert et al. [2009]
reported evidence of anticipation in this cohort. The other
is an aggregation of families seen at the genetic counseling
clinic at the University of Michigan Comprehensive
Cancer Center (UMCCC), with identified mutations in
the MMR gene. The UMCCC data have not been
previously analyzed for anticipation and is a clinical
setting where multiplex ascertainment could influence the
findings. The few studies prior to the one by Nilbert et al.
[2009] have reached contradictory results on anticipation
in Lynch syndrome [Stella et al., 2007; Tsai et al., 1997;
Westphalen et al., 2005]. Our results shed light on the
existing body of literature on anticipation in Lynch
syndrome and the dependence of the inference on the
choice of statistical techniques. For illustration purposes,
we also employ the second class of survival regression
methods described above to analyze data from an
expanded cohort of the Danish HNPCC (Lynch syndrome)
register which evaluates age-at-onset times for proven
MMR mutation carriers (affected/unaffected by a cancer
associated with Lynch syndrome). This enables us to
contrast this study design and the appropriate statistical
methods with the ones involving affected parent-child
pairs. The study thus presents a comprehensive overview
of statistical design and analytic tools to evaluate genetic
anticipation and contributes new data to the assessment of
anticipation in Lynch syndrome families.
The rest of the study is organized as follows. In the
following section, we restrict our attention to the most
common format of data on affected parent-child pairs and
discuss statistical methods to handle the right truncation
bias. Introduction section presents simulation results
comparing existing choices within this class of methods in
the absence and presence of familial ascertainment. The
following section analyzes data on two Lynch syndrome
cohorts using affected parent-child pairs. The penultimate
section discusses the second class of statistical models that
consider all at-risk affected and unaffected family members
and employs a prospective censored regression model. The
Introduction section analyzes expanded family data from
the Danish HNPCC-register with this second class of
methods. The concluding section is subdivided into two
subsections to emphasize the two major contributions of the
paper. The Introduction section presents an integrated
overview of the different statistical approaches, putting
them in the perspective of different sampling mechanisms
and study designs and furnishing a recommendation for a
research investigator. The following section then sum-
marizes the data analysis results on genetic anticipation in
Lynch syndrome, findings which still conflict across studies
and demonstrate a poorly understood phenomenon from a
biological perspective [Larsen et al., 2009; Nilbert et al.,
2009; Rodrı́guez-Bigas et al., 1996; Tsai et al., 1997; Vasen
et al., 1994; Westphalen et al., 2005].
METHODS FOR AFFECTED PARENT-
CHILD PAIRS
Let ðTPi ;TCi Þ be the ages of onset and ðCPi ;CCi Þ the ages at
ascertainment or ages at interview of the ith parent and
child, respectively. While there is no real physical constraint
to the relationship between ðTPi ;TCi Þ and ðCPi ;CCi Þ, we only
observe those pairs which satisfy the condition
fCPi4TPi ;CCi4TCig: ð1Þ
These are the pairs that can be recognized as ‘‘affected’’ at
the time of retrospective assessment of the cohort. Let the
term ‘‘parent-child pair’’ hereafter refer to any pair which
satisfies (1). As mentioned before, comparing the sample
means of TP and TC via the paired t-test ignores that the
data are conditionally observed given (1) and thus leads to
biased inference if follow-up times for the cohort are not
sufficiently long. Huang and Vieland [1997] consider a
conditional likelihood reflecting (1) and propose a para-
metric Wald-type test for this problem. Their method
assumes a joint bivariate normal distribution for ðTPi ;TCi Þ
and is based on the asymptotic normality of the conditional
maximum likelihood estimate (MLE). Using the work of
Huang and Vieland [1997] and Vieland and Huang [1998],
we briefly review the construction of the likelihood.
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Assume that ðTPi ;TCi Þ and ðCPi ;CCi Þ are conditionally
independent given (1). Let f, F denote the joint probability
distribution function (PDF) and cumulative distribution
function (CDF) corresponding to ðTPi ;TCi Þ, and g, G denote
the joint PDF and CDF of ðCPi ;CCi Þ. The conditional
likelihood of the ith parent-child pair is given by,
Li ¼
fðtpi ; tci Þgðcpi ; cci Þ
PrðTPi  CPi ;TCi  CCi Þ
1½tpi  cpi ; tci  cci :
Here 1[A] is the indicator function which assumes the value
1 if event A is true, and is zero otherwise. When g is left
unconstrained (that is, when its governing parameters are
not constrained to be the same as those of f ), Huang and
Vieland [1997] show that the likelihood is proportional to
Li /
fðtpi ; tci Þ
Fðcpi ; cci Þ
: ð2Þ
That is, as long as g is estimated nonparametrically,
maximizing L ¼
Qn
i¼1 Li is equivalent to maximizing
the conditional log-likelihood logðLÞ¼
Pn
i¼1 log fðtpi ; tci Þ=
Fðcpi ; cci Þ. We consider three test statistics which invoke the
general form of this likelihood.
1. The parametric test statistic (HV) [Huang and Vieland,
1997]: HV assumes that f is a bivariate normal distribution
and maximizes log(L) with respect to the mean vector and
covariance matrix of the distribution. Anticipation exists
when the difference in the means of the parents and the
children is greater than zero. An estimate of this effect is
obtained by evaluating the difference of the MLEs, m̂TP  m̂TC ,
with proper standard errors being estimated from the inverse
of the observed Fisher information matrix. Wald-type test
statistics are then constructed, which are standard normal
under the null hypothesis of no anticipation. The HV
approach can be thought of as an adjustment to the t-test
for right truncation, both methods assuming normality.
2. An alternative nonparametric test statistic (RY1)
[Rabinowitz and Yang, 1999]: RY1 uses the quadruples
ðTPi ;TCi ;CPi ;CCi Þ to test the null hypothesis that F is
symmetric, without assuming a particular form of the
distribution F. RY1 is based on all parent-child pairs for
which maxðTPi ;TCi Þ  minðCPi ;CCi Þ. This eliminates the
bias due to truncation because every pair which satisfies
the condition will be observed. Hence,
PrðTCi  TPi jmaxðTPi ;TCi Þ  minðCPi ;CCi ÞÞ ¼ 1=2;
under the null hypothesis of no anticipation. For n parent-
child pairs, the statistic
Xn
i¼1
1½TCioTPi   1=2
 
1½maxðTPi ;TCi Þ  minðCPi ;CCi Þ ð3Þ
is approximately normal with mean 0 and variancePn
i¼1 1½maxðTPi ;TCi Þ  minðCPi ;CCi Þ=4. RY1 can be thought
of as a modification to the Wilcoxon signed-rank test in the
presence of right truncation.
3. A second nonparametric test statistic (RY2) [Rabinowitz
and Yang, 1999]: RY2 compares parents and children
across different pairs. For any i1,i2, the following holds,
assuming no anticipation:
PrðTCi1 oTPi2 jmaxðTCi1 ;TPi2 ÞominðCCi1 ;CPi2 Þ;
maxðTPi1 ;TCi2 ÞominðCPi1 ;CCi2 ÞÞ ¼ 1=2:
The estimator sums over all pairwise comparisons where





ð1½TCi1 oTPi2   1=2Þ1½A;
where
A ¼ fmaxðTCi1 ;TPi2 ÞominðCCi1 ;CPi2 Þ;
maxðTPi1 ;TCi2 ÞominðCPi1 ;CCi2 Þg:
This statistic will also have mean 0 under the null
hypothesis with variance expression provided in
Rabinowitz and Yang [1999].
Remark 1: The efficiency loss of RY1 comes via a
reduction of sample size, as the conditioning event which
eliminates the bias due to truncation will also eliminate
data and restrict inference to a smaller subset (see
Introduction section for a further discussion of this issue).
The extent of this reduction in sample size will depend on
how severe the truncation is. RY2 attempts to compensate
for this loss of data by making comparisons between
parent-child pairs. When this between-pair comparison is
justifiable, i.e., when the parent-child pairs are exchange-
able, this will increase the effective sample size and,
consequently, the power of the test.
Remark 2: In a more recent report, Tsai et al. [2005]
propose a generalized paired t-test and a Wilcoxon signed-
rank test that very similar in spirit to RY1: they restrict
analysis to comparable parent-child pairs which satisfy
maxðTPi ;TCi Þ  minðCPi ;CCi Þ and apply the standard
paired t-test and Wilcoxon signed-rank test to this subset.
Due to its similarity to RY1, we refrain from including this
as a separate method for comparison purposes. One
contribution of Tsai et al. [2005] is to extend the general-
ized t-test to a random effects model that incorporates
family level correlation and introduce a general mixed
model framework to test for a difference in mean ages of
onset across generations; this is more robust and general
than a t-test.
SIMULATION STUDY
Our simulation study was designed to compare the
performance of the above three test statistics (HV, RY1, and
RY2) with the paired t-test under three different ascertain-
ment schema described below. Note that these methods
only use data from affected parent-child pairs. Previously,
Vieland and Huang [1998] provided an extensive discus-
sion on the effect of the ascertainment scheme on the
behavior of HV in terms of Type I error and power but so
far no such simulation results are available for the
nonparametric methods RY1 and RY2 under varying
selection mechanisms. Also, even for an unbiased random
ascertainment, there does not exist any simulation study
directly comparing HV, RY1 and RY2 simultaneously in
terms of power and Type I error. We first describe the
simulation design under each ascertainment scheme and
then summarize our simulation findings.
1. Random Ascertainment (RA): RA draws a simple
random sample of parent-child pairs from the population
of eligible pairs. That is, every parent-child pair for which
both individuals have developed the disease at the time of
ascertainment has an equal probability of selection,
regardless of the size of the pedigree. Simulation of RA
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is straightforward. The ages of onset, (TP,TC), are assumed
to be bivariate normal. (CP,CC), the pair of ascertainment
ages, is assigned to (c1,c2), where c1 is a continuous
uniform random variable, and c2 5 c1d1, where d1 is also
a continuous random variable with parameters such that c1
is guaranteed to be positive. Sample parent-child pairs are
randomly drawn in this manner, and those which satisfy
condition (1) are included in the simulated dataset until n
such pairs have been selected.
2. Generalized Single Ascertainment (GSA) [Hodge and
Vieland, 1996]: GSA samples entire pedigrees and, within
a pedigree, randomly selects a single parent-child pair.
A crucial component of this scheme is that the selection
probability of a pedigree is strictly proportional to the
number of parent-child pairs it contains. [Hodge and
Vieland, 1996] prove, and Hodge and Vieland [1996]
confirm by example, that if pairs are ascertained with
probability proportional to the number of parent-child
pairs in the pedigree, then the correct likelihood is
proportional to the conditional likelihood given the
truncation. This shows that whether the data come from
a true random sample of all possible parent-child pairs (an
unlikely situation) or from GSA, maximizing the condi-
tional likelihood is valid and will yield unbiased estimates.
To simulate GSA, we follow the prescribed methods in
Appendix B of Vieland and Huang [1998] to generate
simple pedigrees. Three ages at ascertainment are drawn
(c1,c2,c3), representing a grandparent-parent-child triad. As
described in RA, c1 is a continuous uniform random
variable, c2 5 c1d1, and c3 5 c1d1d2, where d1 and d2 are
also continuous uniform random variables with para-
meters such that c2 and c3 are guaranteed to be positive.
One of the two possible parent-child pairs (either (c1,c2) or
(c2,c3)) is selected with equal probability and assigned to
(CP,CC). After drawing a single random bivariate normal
pair (TP,TC), if (1) is satisfied, the pair is included in the
dataset, otherwise not. Thus, those pedigrees which have
two affected parent-child pairs are twice as likely to be
selected as those with one pair; this is the condition which
satisfies GSA. (Although (c1,c2) and (c2,c3) are selected with
equal probability, the fraction of young pairs in the
resulting dataset will be less than 0.5, since (c2,c3) will fail
to satisfy (1) more often than (c1,c2).)
3. Multiplex Ascertainment (MA): In MA, pedigrees with
more affected parent-child pairs are ascertained with a
larger probability that is not directly proportional to the
number of affected parent-child pairs. Vieland and Huang
[1998] argue that this results in samples with younger
affected individuals: a pedigree with young affected
individuals will also have many affected individuals,
since the disease tends to present earlier in that pedigree.
Thus, a sampling scheme which preferentially selects
pedigrees with multiple affected individuals will have the
byproduct of having selected many young pairs. This will
artificially create a difference in mean ages of onset
between the parent and the child, even if there is none.
This artificial difference is in addition to that created by
the truncation bias. To simulate MA, then, we ‘‘enrich’’ our
sample with young pairs. Three ages of ascertainment are
drawn, as in GSA. One of the two pairs is selected (the
probability of which determines the level of ‘‘enrichment’’
of young pairs in the dataset), and random draws of
(TP,TC) are made until condition (1) is satisfied.
For each of the sampling schema, our choice of
distributional parameters was governed by previous
simulation studies from Rabinowitz and Yang [1999] and
Vieland and Huang [1998]. Under each simulation config-
uration, we generated 5000 simulated datasets, each with
50 parent-child pairs, and tested the null hypotheses of no
genetic anticipation against a one-sided alternative that the
mean age of onset in parents exceeds the mean age of onset
in children. In each setting, we calculated the proportion of
times the null hypothesis was rejected in 5,000 replications.
When data were generated under the null distribution, this
proportion provided an estimate of Type I error, whereas
under the alternative, it provided an empirical estimate of
power.
Table I provides the simulation results under RA. In
terms of Type I error, the most honest test is RY1, which is
close to its nominal value of a5 0.05 for each set of
generating parameters. HV and RY2 stay just above their
nominal size, while the paired t-test fares poorly. The Type
I error rate of the paired t-test depends crucially on the
amount of truncation; it converges to its nominal value as
the ascertainment distributions increase and the age-of-
onset distributions remain fixed. This is the rationale
behind restricting analysis to older birth cohorts. Under
the alternative, RY1 is the most underpowered, with only
about 35% of simulations able to detect a difference of 5
years under the assumption of uncorrelated ages of onset.
RY2 does slightly better and HV the best. Of course, the
t-test is the most powerful, which is to be expected given
its high rate of false positives.
Remark 3: For all four tests, as the correlation between
the ages of onset increases, performance improves. To
understand this phenomenon, note that ‘‘large’’ values of
TC are the primary cause of a pair being truncated: in the
first three rows of Table I, Pr(TC4CC)E0.32, whereas
TABLE I. Estimated Type I error rates and power
(corresponding to 5,000 simulations with 50 parent-child
pairs per simulation) with nominal significance level





BVN (55, 55, 100, 100, 0.0) 0.858 0.085 0.054 0.067
BVN (55, 55, 100, 100, 0.5) 0.562 0.069 0.048 0.062
BVN (55, 55, 100, 100, 0.7) 0.387 0.064 0.049 0.058
Power
BVN (55, 50, 100, 100, 0.0) 0.996 0.642 0.353 0.543
BVN (55, 45, 100, 100, 0.0) 1.000 0.988 0.826 0.966
BVN (55, 50, 100, 100, 0.5) 0.999 0.912 0.673 0.853
BVN (55, 45, 100, 100, 0.5) 1.000 1.000 0.993 1.000
BVN (55, 50, 100, 100, 0.7) 1.000 0.993 0.891 0.979
BVN (55, 45, 100, 100, 0.7) 1.000 1.000 1.000 1.000
(TP,TC) are the respective ages of onset for the parent and child,
with BVN the bivariate normal distribution with parameters
(mp,mc,sp,sc,r(Tp,Tc)). The ascertainment ages (CP,CC) are deter-
mined by c1Unif(80,90) and d1Unif(20,30) as described in
‘‘Methods for Affected Parent-Child Pairs’’ section. Powers in
bold come from tests which asymptotically fail to maintain
nominal level of significance. Powers in italics come from tests
which are asymptotically unbiased, but, due to small sample size,
have Type I error rates significantly greater than 0.05.
aHuang and Vieland [1997].
bRabinowitz and Yang [1999].
759Statistical Methods for Testing Genetic Anticipation
Genet. Epidemiol.
Pr(TP4CP)E0.002. This truncation inflates the difference
in the observed means, even when no such difference exists
between the true means. When TC is uncorrelated with TP,
knowing that a pair was ascertained does not provide
much information about TP. But, as the correlation
increases, small TC becomes associated with small TP, the
bias from truncation decreases, and, under the null, test
statistics converge to the correct asymptotic distribution
faster. Under both the null and non-null scenario, presence
of a positive correlation leads to increased precision for
estimating the mean differences for a fixed n. The fact that
HV is most sensitive (among the three asymptotically
unbiased statistics HV, RY1 and RY2) to changes in r can
be understood further by observing that the computation
of HV involves calculating r̂, the estimated correlation
between TP and TC, by maximizing a profile likelihood. We
noted in our simulation that this estimator r̂ generally
becomes more precise as r departs from the null value of
zero: the estimated mean squared error of r̂ when r5 0 is
2.92 102 but is 1.98 102 when r5 0.5, providing a
estimated relative efficiency of 68%. Moreover, in small
samples, r is slightly overestimated when the true value is
0, causing the variance of the difference in mean age of
onset to be underestimated and the null hypothesis of no
anticipation to be rejected more often than desired. On the
other hand, RY1 and RY2, which do not directly use an
estimate of r in their calculation and are non-parametric
tests, remain less affected.
Table II displays the estimated Type I error rates and
power under GSA. As before, RY1 is consistently close to
its nominal significance level, and RY2 and HV do
reasonably well. The paired t-test, again, falsely rejects
the null many more times than its nominal size suggests.
Power rankings are also as before, with RY1 performing
the worst and HV almost as powerful as the t-test. As was
the case under RA, greater correlation decreases Type I
error and increases power.
Table III simulates multiplex ascertainment, varying the
level of enrichment of young pairs for a fixed set of
generating distributions. As before, RY1 commits the
expected number of Type I errors. The paired t-test performs
very poorly, rejecting the null hypothesis with probability 1
for sufficient levels of enrichment. The number of false
positives HV yields increases with increasing enrichment.
Unlike the prior ascertainment schema, this inflation cannot
be solely attributed to small sample sizes; as shown by
Vieland and Huang [1998], the method does incur inflated
Type I error under multiplex ascertainment. Besides the
t-test, HV is the most powerful test statistic. Both the
nonparametric test statistics lose power precipitously with
increasing enrichment. In this setting, since the t-test and HV
do not maintain nominal Type I error, we present two
combined measures of precision, the accuracy (ACC) and
positive predictive value (PPV), defined as
ACC ¼







Note that here the ACC and PPV measures are used not in
the sense of a diagnostic test but rather as a combined
TABLE II. Estimated Type I error rates and power
(corresponding to 5,000 simulations with 50 parent-child
pairs per simulation) with nominal significance level





BVN (55, 55, 100, 100, 0.0) 0.906 0.078 0.051 0.065
BVN (55, 55, 100, 100, 0.5) 0.653 0.049 0.051 0.063
BVN (55, 55, 100, 100, 0.7) 0.444 0.044 0.050 0.055
Power
BVN (55, 50, 100, 100, 0.0) 0.994 0.635 0.330 0.521
BVN (55, 45, 100, 100, 0.0) 1.000 0.988 0.778 0.951
BVN (55, 50, 100, 100, 0.5) 1.000 0.799 0.633 0.834
BVN (55, 45, 100, 100, 0.5) 1.000 0.997 0.984 1.000
BVN (55, 50, 100, 100, 0.7) 1.000 0.931 0.854 0.968
BVN (55, 45, 100, 100, 0.7) 1.000 0.997 0.999 1.000
(TP,TC) are the respective ages of onset for the parent and child,
with BVN the bivariate normal distribution with parameters
(mp,mc,sp,sc,r(Tp,Tc)). The ascertainment ages (CP,CC) are deter-
mined by c1Unif(80,90) and d1,d2Unif(20,30) as described in
‘‘Methods for Affected Parent-Child Pairs’’ section. Powers in
bold come from tests which asymptotically fail to maintain
nominal level of significance. Powers in italics come from tests
which are asymptotically unbiased, but, due to small sample size,
have Type I error rates significantly greater than 0.05.
aHuang and Vieland [1997].
bRabinowitz and Yang [1999].
TABLE III. Estimated Type I error rates, Power, Accuracy
and Positive Predictive Value (corresponding to 5,000
simulations with 50 parent-child pairs per simulation)
with nominal significance level a 5 0.05 under Multiplex
Ascertainment for 4 test statistics. ‘‘Percent Young’’ is the
level of enrichment of young pairs
Percent
t-test HVa RY1b RY2b t-test HVa RY1b RY2b
Young Type I Error Power
0.1 0.975 0.066 0.049 0.061 1.000 0.989 0.776 0.953
0.3 0.999 0.060 0.046 0.064 1.000 0.973 0.685 0.900
0.5 1.000 0.068 0.052 0.068 1.000 0.926 0.563 0.796
0.7 1.000 0.102 0.048 0.053 1.000 0.848 0.391 0.536
0.9 1.000 0.160 0.052 0.020 1.000 0.745 0.201 0.079
Accuracy Positive predictive value
0.1 0.513 0.962 0.864 0.946 0.506 0.937 0.941 0.940
0.3 0.501 0.957 0.820 0.918 0.500 0.942 0.937 0.934
0.5 0.500 0.929 0.756 0.864 0.500 0.932 0.915 0.921
0.7 0.500 0.873 0.672 0.742 0.500 0.893 0.891 0.910
0.9 0.500 0.796 0.575 0.523 0.500 0.823 0.794 0.798
For all rows, the ages of onset for the parent and child are
generated from (TP,TC)BVN(55, 55, 100, 100, 0) (Type I Error) or
BVN(55, 45, 100, 100, 0.0) (Power). The parameters associated with
the ascertainment distributions are c1 and (d1,d2) as described in
‘‘Methods for Affected Parent-Child Pairs’’ section, with
c1Unif(80,90), and d1,d2Unif(20,30). Powers in bold come from
tests which asymptotically fail to maintain nominal level of
significance. Powers in italics come from tests which are
asymptotically unbiased, but, due to small sample size, have
Type I error rates significantly greater than 0.05.
aHuang and Vieland [1997].
bR bi it d Y [1999]
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metric of Power and Type I error, just as mean squared
error is a combined measure of bias and variance in the
context of estimation. For example, these measures have
recently been used to assess properties of statistical tests
for genetic association which do not strictly maintain
Type I error level in the context of combining individual
and family-based studies [Mirea et al., 2010]. All three test
statistics, HV, RY1, and RY2, outperform the paired t-test
in terms of these metrics. HV performs best for all levels of
enrichment; its strength is most evident in terms of its
accuracy for high levels of enrichment. The loss of power
is not nearly as dramatic as for the nonparametric tests,
and this outweighs its increase in Type I error. Between
RY1 and RY2, RY2 would be preferred in terms of both
metrics.
Remark 4: In Tables I–III, we noted that HV has the
highest power, while the nonparametric tests, RY1 and
RY2, lack power in spite of adhering to nominal Type I
error rates under a wide spectrum of scenarios. Recall that
in all these simulation settings we generated the age-
of-onset distribution from a bivariate normal distribution.
Thus, the parametric modeling assumption of HV was
exactly satisfied by the generated data. To assess the
sensitivity of HV in terms of model misspecification, we
generated ages of onset from a bimodal distribution,
governed by a two-component mixture of Normals (results
not shown). Under this setting, HV has slightly inflated
error rates compared to the more robust RY statistics but
still retains its power advantages in most cases. This trade
off between robustness and efficiency is expected in
comparing any parametric method with its nonparametric
counterpart.
EXAMPLE: APPLICATION TO LYNCH
SYNDROME DATA FROM AFFECTED
PARENT-CHILD PAIRS
In addition to the above simulation studies, we applied
these methods to two cohorts of families with genetic
predisposition to Lynch syndrome (previously better
known as hereditary nonpolyposis colorectal cancer
(HNPCC), but first known as a cancer family syndrome
[Warthin, 1913], characterized by the early onset of
gastrointestinal, uterine and other cancers). In 1991, the
Amsterdam criteria were developed for inclusion of
families in HNPCC studies to identify causal genes [Vasen
and Mecklin, 1991; Vasen et al., 1999]. The genetic basis of
Lynch syndrome is germline mutation in MMR genes,
with four genes known so far to be causally responsible for
Lynch syndrome (hMSH2, hMLH1, hMSH6, and hPMS2).
The possibility for anticipation has been suggested, some-
times by anecdotal observation or subjective observation
of the data [Menko et al., 1993; Rodrı́guez-Bigas et al.,
1996; Vasen et al., 1994] and sometimes by formal
statistical analysis [Nilbert et al., 2009; Westphalen et al.,
2005]. In a carefully done analysis in Tsai et al. [1997]
consisting of 475 pairs selected from 308 families identified
through the Hereditary Colorectal cancer registry at John
Hopkins University, no evidence of anticipation was
noted. However, the nature and definition of our cohort
is quite different from the Tsai et al. study where only 14
out of the 475 pairs were from seven families identified
with germline mutations in hMSH2 or hMLH1.
Our first dataset consisted of 74 families, each with an
identified deleterious MMR mutation, seen at the genetic
counseling clinic at the UMCCC. The index cases
presented to the clinic between 1999 and 2009. Thus, the
clinical data are very likely to be subjected to multiplex
ascertainment as discussed in the Introduction section.
Cancers that qualified as a part of Lynch syndrome were
colorectal cancer, endometrial cancer, epithelial ovarian
cancer, upper urothelial cancer, gastric cancer, cancer of the
small intestine, and malignant brain tumors. Out of these
74 families, 57 had at least one affected parent-child pair,
leading to 181 affected parent-child pairs in the database.
For patients with multiple cancers, the first was used to
establish the age of onset. Due to missing age-of-onset
information, some pairs were deleted from the current
analysis, and the final analysis was restricted to 136
parent-child pairs with complete age-of-onset information
coming from 47 MMR-positive families. The maximum
number of pairs coming from a single family was 15 with
an average of 3.53 pairs coming from each pedigree. The
final dataset consisted of 190 individuals. The date of
ascertainment was taken as the date of interview with the
proband. For relatives with missing date of birth, age at
ascertainment was estimated from a prediction model
based on the proband/index person’s year of birth and
relationship to the proband/index person. Construction of
the family cancer history was based on interviews with the
proband by a trained genetic counselor and cross-verified
by interviews with other family members. Absence of
confirmatory medical records to verify ages of onset was
an obvious limitation of this cohort. We will refer to this
cohort as UMLYNCH from now on.
The other dataset we considered comes from the Danish
HNPCC-register on all Danish families identified with
hereditary colorectal cancer from 1991 until December
2006. The Lynch syndrome cohort was defined as 151
families with pathogenic MMR gene mutations. Out of
these 151 families, 92 families contained at least one
affected parent-child pair. The final cohort consisted of 400
individuals making up 290 parent-child pairs. Unverifi-
able cancers were ignored, and, for patients with multiple
cancers, the first was used to establish the age of onset.
Nilbert et al. [2009] analyzed this data in a prior study
using the paired t-test and HV but did not apply the
methods of Rabinowitz and Yang [1999]. We will refer to
this cohort as DLYNCH from now on. In comparison to
UMLYNCH, DLYNCH has more complete age-of-onset
information and the advantage of having verified medical
history data. From Table IV, the mean age at diagnosis for
all individuals in UMLYNCH was 47.1 year, compared to
46.8 year in DLYNCH.
Remark 5: Since the objective of this article is to provide a
review and comparison of existing methods, our simula-
tion studies only considered the originally proposed test
statistics (t-test, HV, RY1, RY2) and generated independent
parent-child pair data with one pair per family. However,
the data analysis results presented in this section are
modifications of the original test statistics in the sense that
they make adjustments for the correlation that may
potentially exist between multiple pairs sampled from
the same family, which is the case for both UMLYNCH and
DLYNCH cohort. For the parametric methods (t-test and
HV), we used robust sandwich estimators of the standard
errors based on the score residuals summed over each
family. For the nonparametric methods (RY1 and RY2) we
extended the original variance formulae to accommodate
between-pair correlation within the same family (assumed
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to be constant across families). More specifically, from the
theory of U-statistics, both RY1 and RY2 can be asympto-
tically represented in the form
Pn
i ui(with i indexing each
pair and n being the total number of pairs) where exact
expressions for ui and the corresponding variance approx-
imations under the independence assumption are pro-
vided in Rabinowitz and Yang [1999]. The original
unadjusted variance estimates assume that Var ui ¼ s2u
for i 5 1,y,n and Cov ðui; ujÞ ¼ 0 for i6¼j. Thus,dVar Pni ui ¼ nŝ2u. We introduce a familial correlation
structure by letting Cov ðui; ujÞ ¼ rus
2
u when i and j come








pairs in family k
2
 " #
with the convention that 12
 
¼ 0. This serves to adjust for
the artificial increase in sample size due to incorrectly
assuming between-pair independence. The estimates ŝ2u
and ru are obtained from the empirical variance and cross-
correlation of ûi, with ûi as described in Rabinowitz and
Yang [1999].
Table V provides the correlation-adjusted version of the
set of four test statistics discussed in the earlier section. We
first discuss the analysis that includes all pairs. The paired
t-tests, even with robust standard errors, as might be
expected, display high levels of significance, with ob-
served differences in mean ages of onset of 9.89 years for
UMLYNCH (Po0.0001) and 8.72 year for DLYNCH
(Po0.0001). Similar evidence is obtained by RY2
(Po0.0067) in UMLYNCH and (Po0.0001) in DLYNCH).
HV gives only slight evidence of genetic anticipation in
UMLYNCH (Po0.0294) compared to DLYNCH
(Po0.0001), and RY1 applied to UMLYNCH shows no
significance (P 5 0.5) whereas DLYNCH shows signifi-
cance (Po0.0046). This last observation is explained by the
fact that in UMLYNCH, only 62 pairs qualified in the
construction of RY1, limiting the power and reliability of
the analysis (as discussed in Remark 1 of the earlier
section). Results from DLYNCH show greater levels of
significance than UMLYNCH for all the tests we con-
sidered, which is explained by the larger sample size of
DLYNCH.
Considering only those pairs where both individuals
had colorectal cancer, the difference in mean ages of onset
increased in both datasets (11.19 years in UMLYNCH,
11.01 years in DLYNCH); with one exception (HV in
DLYNCH), the significance level dropped slightly across
the board due to the reduced sample size in this subgroup.
In UMLYNCH, mutation status was known for 46 out of
190 individuals. Since this is a small number of subjects,
TABLE IV. Summary of UMLYNCH and DLYNCH with numbers of individuals, mean ages of diagnosis (aod) and
standard errors (SE) by cancer type and mutation status
UMLYNCH DLYNCH
n Mean aod (SE) n Mean aod (SE)
All individuals 190 47.1 (13.7) 400 46.8 (12.3)
Cancer Colorectal 130 45.7 (13.7) 266 46.4 (13.1)
Other 60 50.1 (13.3) 134 47.7 (10.6)
Mutation hMSH2 27 44.9 (15.3) 207 46.5 (11.4)
hMLH1 18 42.7 (11.6) 134 44.6 (13.0)
hMSH6 1 70.0 (NA) 59 52.9 (12.1)
Unknown 144 47.8 (13.5) 0
Total Pairs (n) 136 290
Cancers in the ‘‘Other’’ category include brain tumors, ovarian, rectal, cancer of the small intestine, stomach, endometrial, cancer of the
ureter, and upper urothelial cancer.






Subset Pairs (n) in means t-test HVb RY1c RY2c Pairs (n) in means t-test HVb RY1c RY2c
Entire cohort 136 9.89 5.65 1.89 0.00 2.47 290 8.72 7.77 4.10 2.60 4.67
Only CRC 62 11.19 4.53 1.82 0.10 2.28 130 11.01 6.68 4.25 2.01 3.85
MSH2 Not analyzed due to missingness 153 7.58 5.13 2.85 2.09 2.86
MLH1 92 10.10 4.28 2.51 1.21 3.74
MSH6 41 9.76 4.29 1.74 1.05 2.08
‘‘Only CRC’’ considers those parent-child pairs where both had colorectal cancer and, for DLYNCH, ‘‘MSH2,’’ ‘‘MLH1,’’ and ‘‘MSH6’’
stratify by mutation type.  indicates a P-value less than 0.0001,  less than 0.001, and  less than 0.01.
aWith adjustments to the variance estimates for correlation of multiple pairs coming from the same family.
bHuang and Vieland [1997].
cRabinowitz and Yang [1999].
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stratified analysis by gene-specific mutation type was not
feasible. In DLYNCH, where complete data were available
on mutation status, the gene most commonly mutated was
hMSH2 (153/290 pairs). The difference in mean ages of
onset in successive generations restricted to hMSH2
mutation carriers was 7.58 years, and all three test statistics
(HV, RY1, and RY2) displayed only marginal statistical
significance (0.01oPo0.05). Among those with a mutation
in the hMLH1 gene, the difference in mean ages of onset
was larger, 10.10 years, and HV and RY1 were less
significant; however, RY2 was actually considerably more
significant (Po0.0001). The hMSH6 group had a differ-
ence of 9.76 years and was least significant due to only 41
pairs.
For the sake of completeness, the data analysis results
using the test statistics as proposed in the original articles
and discussed in the earlier section, without adjusting for
correlation among pairs coming from the same family are
presented in Table AI and, as expected, they are inflated
relative to the adjusted results in Table V. Table AII
provides the inverse variance-weighted pooled estimates
[DerSimonian and Laird, 1986] combining UMLYNCH
and DLYNCH estimates from the full cohort correspond-
ing to Table AI. The pooled estimates from the t-test,
HV, and RY2 still show strong statistical significance,
whereas RY1 fails to reach significance. The same finding
holds for adjusted estimates presented in Table V when
pooled.




Anticipation is a phenomenon which can be addressed
via study designs beyond a retrospective comparison of
mean ages of onset of affected parent-child pairs in a
(possibly truncated) cohort. The second genre of methods
and thus study designs considers a well-defined cohort of
all at-risk affected and unaffected individuals and applies
censored regression models and classical survival analysis
techniques to test for a generational effect.
Hsu et al. [2000] proposed two nonparametric matched
and unmatched test statistics based on multivariate
survival analytic techniques that consider both affected
and unaffected family members and potential correlation
between the ages of onset within a family. For unaffected
individuals, Hsu et al. consider age at last follow-up or age
at death and include this information while differentiating
the age-of-onset distribution in two successive genera-
tions. This approach cannot incorporate other covariates.
However, their idea of including all affected/unaffected
pairs is further extended into a general survival regression
framework in the following two more recent papers. The
advantages of these censored regression models are the
flexibilities to incorporate other covariates, environmental
factors, screening practices, or secular trends as needed.
They are also easily amenable to incorporate familial
correlation using standard techniques for correlated failure
time data [Kalbfleisch and Prentice, 2002].
1. Normal random effects model (REM): Larsen et al. [2009]
employ a normal random effects model in the following
study setting. Pedigrees known to be carriers for mutations
in one of the MMR genes are identified, and all at-risk
members of these families (affected or unaffected) are
followed until disease diagnosis or time of censoring.
The study uses a superset of DLYNCH. Let tij be the
age to disease diagnosis for the jth individual in the ith
family. Larsen et al. posit the following model:
Tij ¼ ui1bXij1gZij1eij ð4Þ
where ui is a family-specific random effect, Zij is the
generation of the jth individual in the ith family (with the
oldest individual in a family being denoted as first
generation with Zij 5 1), g is the fixed effect of generations,
and eij is the residual with mean zero and a given variance
component. All random effects u and e are assumed to be
independent. When g5 0, there is no change in time to
disease diagnosis across generations. Random family
effects account for within family correlation, and fixed
effects for other covariates can be added to the model, as
the term bXij represents in (4). The likelihood is adjusted
for censoring indicators, assuming censoring is non-
informative with respect to age of onset.
2. Cox proportional hazards model (CPH): Daugherty et al.
[2005] use a Cox proportional hazards model under
the following study design: families with at least one
affected individual are first ascertained, and all parents
and children of affected individuals are followed until
the cancer event (disease diagnosis) or time of censoring.
Let tij again be the age of onset for member j in family i.
The following marginal proportional hazards model is
assumed:
lðtijjXij;XijÞ ¼ l0ðtijÞ expðb
Xij1gZijÞ: ð5Þ
The term l0 is the baseline hazard function, Xij are other
relevant measured covariates for a given individual, and
Zij is a binary indicator of relative type (0 for offspring and
1 for parent). Evaluating H0:g
5 0 evaluates the relative
hazard between parents and offspring. Estimation of b
and g are carried out via a working independence
assumption, but, by using a robust sandwich estimate of
the covariance matrix, within-family correlations can be
accounted for. Despite these strengths, however, the model
answers the question of anticipation at the generational
level and not the familial level; that is, all parents are
assumed to have the same hazard function and all children
another. This is problematic for two reasons. First, the
degree of anticipation in one family may be different than
the degree of anticipation in another, yet both are
constrained to have the same hazard. The matched statistic
of Hsu et al. [2000] addresses this issue of heterogeneity of
hazards across families. Second, when three consecutive
generations are considered, the middle individual plays
the role of a child in one parent-child pair and that of a
parent the other. The same individual will thus have two
predicted hazards, one as a child and one as a parent
according to this model. This also artificially inflates the
sample size. To overcome this second limitation of
their approach, we slightly modify the model, letting Zij
denote the generation of person j in family i (as in REM).
This slightly changes the interpretation of g, which
now becomes the hazard ratio between two successive
generations.
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APPLICATION OF CENSORED REGRESSION
MODELS TO EXPANDED DANISH COHORT
For illustration purposes of the second class of methods
as well as to understand the differences in defining the
study cohort, we return to the Danish HNPCC registry and
consider the same dataset analyzed in Larsen et al. [2009].
The dataset consists of 816 individuals who are mutation
positive for one of the three MMR genes, coming from 155
pedigrees. Lynch-associated cancer developed in 568
individuals by December 2007. Zij took values in
f1; 2; 3; 4g, with Zij 5 1 corresponding to the oldest member
of a family. Excluding censored individuals, the mean ages
of onset were 53.0, 45.2, 40.0, and 25.0 years in generations
1,2, 3, and 4, respectively.
Let Xij 5 1[Individual j in family i is male] in (4) and (5),
so that b, here 1-dimensional, characterizes the increase (or
decrease) in age at diagnosis between males and females,
and b, also 1-dimensional, gives the log-hazard ratio
between males and females, all other factors being equal.
See Larsen et al. [2009] for details of the derivation of the
likelihood of (4), where censored observations must be
taken into account. Maximization of the likelihood can be
accomplished via standard optimization routines or via a
grid search, and standard errors can be calculated by
inverting the Hessian of the maximum likelihood esti-
mates. Standard software packages will estimate para-
meters and standard errors for (5), this being the regular
partial likelihood of the Cox proportional hazards model.
Table VI gives parameter estimates and test statistics under
both REM and CPH model.
REM estimates of g indicate that each generation within
a family, adjusting for gender, develops Lynch syndrome
about 3 years sooner than the previous generation; this
effect is highly significant (Po0.0001). As mentioned
before, we modified the CPH approach of Daugherty
et al. [2005] slightly by defining Zij not as a dichotomous
classifier but as the generation of the jth individual in the
ith family. CPH estimates g, the difference in the log-
hazards between two consecutive generations, to be 0.222
(P 5 0.001). The hazard for generation k11 is about
e0.222 5 1.25 times higher than the hazard for generation
k, k 5 1,2,3. The gender effect is not significant in REM
and only marginally so in CPH, but both indicate that
men with Lynch Syndrome tend to be diagnosed with
cancer at a later age than women. The interpretation/
magnitudes of g and g are not directly comparable (as is
also the case with b and b), although, in both cases, the
null hypothesis of no genetic anticipation H0:g(or g
) 5 0 is
rejected.
DISCUSSION
Since the study has a two-pronged objective of review-
ing analytical choices to assess genetic anticipation and
adding new evidence to the context of Lynch syndrome,
we separate the two discussion items and summarize our
findings.
CHOICE OF STATISTICAL METHODS
The primary objective of the paper is to provide the
reader with a sense of the gamut of statistical techniques
that can be used to assess genetic anticipation, depending
on their choice of cohort. We clearly delineate contrasting
statistical issues when one assesses generational effects on
the age of onset using just affected parent-child pairs
versus affected and unaffected family members at risk.
Collecting data under the first design is probably easier,
because gathering information on unaffected relatives
often requires substantial work. However, the censored
regression models are more powerful, since each family
contributes the additional information of its unaffected
members. The second class of methods falls under
the well-developed realm of regression models for
censored data and allows the immediate extension to the
inclusion of covariates and correlations among ages of
onset.
The simulation study in the study is also the first one to
compare the parametric and nonparametric methods that
address the issue of truncation bias. We evaluate the
performance of these alternatives under different ascer-
tainment schema and model misspecification. Using solely
Type I error as a metric, RY1 is consistently the preferred
test statistic across all ascertainment schema, among any
set of generating parameters we considered. However, as
demonstrated in Tables I–III, its power, even for an effect
as large as a difference in 10 years in mean age of onset,
can be unacceptably small. We notice this limitation in our
TABLE VI. Analysis of expanded DLYNCH data of all at-risk individuals from MMR carrier families using a normal
random effects model (REM) and Cox proportional hazards model (CPH)
REMa CPHb
Parameter Estimate (SE) Wald P-value Parameter Estimate (Robust SE) Wald P-value
E(ui) 55.03 (1.36) o0.0001 g (Generation) 0.22 (0.07) 0.0014
g (Generation) 3.28 (0.61) o0.0001 b (Gender) 0.17 (0.08) 0.0300
b (Gender) 1.22 (0.93) 0.1870
Var (ui) 11.17 (4.77)
Var (eij) 135.76 (8.92)
For REM, ui is the family-wise random intercept, g is the effect of generation on time to diagnosis, and b is the expected difference between
males and females in time to diagnosis. For CPH, g is the log-hazard ratio corresponding to generation, and b is the log-hazard ratio
corresponding to gender. Gender is coded as Male 5 1 and Female 5 0, whereas generation can take values 1, 2, 3, and 4, with 1 representing
the oldest generation in a family.
aLarsen et al. [2009].
bDaugherty et al. [2005].
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data analysis as well, where RY1 appears to have a non-
significant/less significant result in contrast to HV and
RY2. This is because many parent-child pairs get excluded
from the construction of the RY1 test statistic. For example,
in the last row of Table III, over 5000 simulations, an
average of 5.58 pairs (out of 50) satisfied 1½maxðTPi ;TCi Þ 
minðCPi ;CCi Þ (see expression (3) above). Thus, the hypoth-
esis was typically accepted or rejected based on only 5 or 6
parent-child pairs, with all the others being excluded from
the sample. In some simulations, no parent-child pairs
satisfied the criterion for being retained and RY1 is not
defined in that case. The highest level of enrichment
simulated in Table III was 90%. HV has inflated Type I
errors of approximately 16% in this instance. Although
these extreme levels of enrichment do inflate HV’s Type I
error, for a modest level of enrichment (50–60%), the Type I
error is still within an acceptable range. RY2 also maintains
Type I error, but under extreme enrichment, (90%) it is
very conservative with Type I error rate lower than
nominal level (0.02).
In terms of power, because we generated data from the
bivariate normal distribution in Tables I–III, HV was
superior as expected. However, the nonparametric RY
methods are valid over any distributional form of the
age-of-onset distribution in terms of Type I error rates.
Among the two nonparametric methods, RY2 has better
power properties than RY1 across all simulation settings.
Given the operating characteristics of these procedures
across simulation settings, we recommend calculating HV
and RY2, and examining the results of both procedures, so
as to strike a balance between bias and efficiency. If there
is the possibility of multiplex ascertainment strongly
influencing the results, or major violation of the normality
assumption, one should trust RY2 more than the HV
method in order to avoid the chance of yielding false
positives.
Remark 6: A referee suggested comparing the methods in
the Introduction section (affected parent-child pairs) with
methods in the earlier section (all affected and unaffected
family members at risk). Since the two classes of methods
are based on two different designs, it is hard to structure a
realistic simulation study that will be meaningful to
compare across all six tests (Design 1: t-test, HV, RY1,
RY2; Design 2: REM and CPH) based on generated
pedigree data. Note that REM and CPH always maintain
Type I error as they are valid statistical tests under the
given survival regression model. To provide an approx-
imate sense of relative power across the six tests, we
re-sampled the extended DLYNCH data with pedigree
sizes of 25, 50, and 75 respectively and applied the
Introduction section methods to the affected parent-child
pairs from the sampled families and applied the methods
described in the earlier section to the entire sampled
family. The results are presented in Table AIII. We note
that HV, RY2, and REM are the most powerful statistical
tests. Since REM uses data from all family members
and is a likelihood-based parametric approach, it is
the most powerful method. The CPH and RY1 appear
to be less powerful tests in this context. The loss of
power in CPH as compared to REM may be attributed to
the use of robust sandwich estimator of variance
to account for familial correlation in CPH, whereas
REM is a model-based approach, modeling the age-
of-onset times directly via a normal random effects
model.
LOOKING FOR AN ANSWER IN LYNCH
SYNDROME?
In the context of Lynch syndrome, new evidence in favor
of genetic anticipation is added through the analysis of
UMLYNCH. UMLYNCH arguably falls under more severe
multiplex ascertainment than DLYNCH; a likely catalyst
for probands/index persons to present at the clinic is
multiple affected family members with early age of onset.
On the other hand, DLYNCH data are a richer, population-
based database of larger size, with cancers verified
through medical records, clinical records, and death
certificates, as well as complete characterization of muta-
tion status. Despite these differences, there is a surprising
amount of agreement between UMLYNCH and DLYNCH
cohorts in terms of the mean age of onset, their mean
differences across generations, and effect sizes in terms of
genetic anticipation. We analyzed the datasets by all four
methods, after adjusting for correlation between pairs
coming from the same family, and the generally significant
results with Po0.01 (except HV and RY1 in UMLYNCH)
are indeed reassuring. Our simulation results (Table III)
indicate that under multiplex ascertainment, RY1 and RY2
are valid procedures, maintaining correct Type I error rates
with RY2 having more power to detect a given effect size.
Thus, using RY2, the risk of false positives from an inflated
Type I error due to multiplex ascertainment is not a
concern in our analysis of UMLYNCH and DLYNCH. The
analysis of the expanded DLYNCH data also presents
strong evidence in favor of genetic anticipation in Lynch
Syndrome by both a random effects and a proportional
hazards model.
There are other considerations that add complexity to
the situation. While age of onset is an important indicator
for anticipation, there may also be anticipation exhibited
through more aggressive disease severity. In Lynch
syndrome, for example, this can be measured by the
number of cancers/tumors or the stage of the tumor.
Ideally, the measured response then would be multi-
variate, taking into account all these outcomes via a
multivariate response model. As mentioned in the
introduction, bias in estimates may result from a change
in screening practices over time. For the case of Lynch
syndrome, an increase in the rate of colonoscopies or a
decrease in the mean age of first colonoscopy may lower
the mean age at diagnosis apart from the effects of genetic
anticipation. For retrospective data, this may mean
stratifying analysis by time relative to the introduction of
the colonoscopy as a common diagnostic tool. A model-
based approach to this bias would be the inclusion of an
indicator variable for whether the individual was diag-
nosed before or after the introduction of the colonoscopy.
Incorporating detailed colonoscopy records would be a
critical contribution toward arriving at the truth. In the
Danish registry, information on all colonoscopies were not
available, but if an adenoma had been identified at
screening, this information was entered in the popula-
tion-based pathology register and at-risk individuals were
censored at this time.
Another addition to the regression-based approaches in
the earlier section would be the expansion of the random
effects model; a referee pointed out that a constant random
intercept alone might not properly account for familial
correlations of larger datasets, and each family may have an
individual random slope for generational effects. Changing
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the fixed effect g to a random effect gi in (4) would allow for
additional flexibility in the model, and family-wise predic-
tions of gi may be of clinical interest. We are currently
investigating this model from a Bayesian perspective.
Finally, detecting anticipation statistically does not
necessarily suggest a plausible mechanistic explanation
to genetic anticipation in Lynch syndrome. Before the
biological basis of anticipation had been demonstrated in
several specific disorders, the phenomenon was thought to
be due to sampling bias, epigenetic effects, gene conver-
sion, or recombinant events. Since then, the biological basis
for anticipation in a number of neurodegenerative dis-
orders has been shown to be attributable to trinucleotide
repeat instability, with expansion of repeats clearly
correlated with an earlier age of onset. While molecular
instability due to MMR gene mutation is a natural
hypotheses for anticipation in Lynch syndrome, there is
no mechanistic data to support this. Recently, telomere
shortening has been suggested as the mechanism for
anticipation [Vulliamy et al., 2004]. Anticipation has been
hard to study in cancer genetic syndromes. However, new
evidence from studies of Li-Fraumeni syndrome (LFS)
suggest telomere shortening as an alternative mechanism
[Tabori et al., 2007]. Accelerated telomere attrition has been
reported in affected carriers with LFS compared with
unaffected carriers as well as compared with normal wild-
type controls, leading investigators to speculate that
defects in TP53 allow cells with shorter telomeres to
escape senescence and proliferate. If this type of selection
for shorter telomeres applies to both somatic and germline
tissues, then one would expect that shorter telomeres
would be identified at birth in each successive generation.
Whether this hypotheses is tenable for Lynch syndrome is
a question that still remains to be answered. The National
Comprehensive Cancer Network’s guidelines recommend
initiating colonoscopy at age 20 to 25 or 10 years before the
earliest diagnosis in carrier families, and these new data
clearly support enhanced surveillance for mutation car-
riers at a young age. Except for the Tsai et al. [1997] study,
all published data have so far presented evidence in favor
of genetic anticipation in Lynch syndrome. Further
mechanistic studies are needed to arrive at the true answer
to this important question.
Software: Annotated R codes for implementing all these
methods are available at http://www.sph.umich.edu/
bhramar/publichtml/research/.
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APPENDIX
Data analysis results with no adjustments for within-
family correlation are presented in Table AI. Table AII
provides pooled estimates of the test statistics. A compar-
ison of all methods using resampling methods is given in
Table AIII. Finally, a schematic classification of all
statistical methods considered is given in Figure A1.






Subset Pairs (n) in means t-test HVb RY1c RY2c Pairs (n) in means t-test HVb RY1c RY2c
Entire cohort 136 9.89 7.42 3.11 0.00 3.05 290 8.72 9.84 4.73 2.97 5.39
Only CRC 62 11.19 5.06 2.74 0.18 2.85 130 11.01 8.54 4.41 2.65 4.89
MSH2 Not analyzed due to missingness 153 7.58 6.38 3.33 2.51 3.59
MLH1 92 10.10 6.18 2.89 1.21 3.75
MSH6 41 9.76 4.32 1.90 1.13 2.00
‘‘Only CRC’’ considers those parent-child pairs where both had colorectal cancer and, for DLYNCH, ‘‘MSH2,’’ ‘‘MLH1,’’ and ‘‘MSH6’’
stratify by mutation type.  indicates a P-value less than 0.0001,  less than 0.001, and  less than 0.01.
aWith no adjustments to the variance estimates for correlation of multiple pairs coming from the same family. These results are obtained by
direct use of the test statistics as proposed in the original papers.
bHuang and Vieland [1997].
cRabinowitz and Yang [1999].
TABLE AII. Pooled estimator from combining the UMLYNCH and DLYNCH estimators for genetic anticipation (from
Table AI—not adjusted for within-family correlation); the method for pooling used was that prescribed by DerSimonian
and Laird [1986] for combining estimates across studies with different sample sizes, using the inverse variances as
weights
N t-test HV RY1 RY2
UMLYNCH 136 7.42 3.11 0 3.05
DLYNCH 290 9.84 4.73 2.97 5.39
POOLED 426 12.29 5.64 1.39 3.79
TABLE AIII. Estimated proportion of rejection with 2,500 resampled datasets with n 5 25, 50, 75 pedigrees from the
expanded DLYNCH dataset containing 155 families
Design 1 Design 2
n Method: t-test HV RY1 RY2 REM CPH
25 Rejection Rate: 0.956 0.615 0.330 0.693 0.703 0.525
50 0.999 0.826 0.505 0.876 0.905 0.628
75 1.000 0.925 0.671 0.947 0.971 0.764
The first four estimates under Design 1 are based on affected parent-child pairs sampled from the selected families, whereas the two tests
under Design 2 use all affected and unaffected family members. The tests that may not maintain Type I error under multiplex
ascertainment are presented in bold font.
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Fig. A1. A schematic classification of statistical methods for testing genetic anticipation with corresponding references.
768 Boonstra et al.
Genet. Epidemiol.
